Shanghai, China, September 07, 2026 --(PR.com)-- Driven by rapid development in global biopharma, pharma firms, laboratories, CRO/CDMOs and IVD manufacturers are confronted with fragmented supply networks, scattered supplier resources, complicated cross‑border compliance barriers, unstable product quality, variable batch bioactivity and extended procurement lead‑times.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Nick
Contact Nick, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack